The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Biologic risk model for recurrence in resected early-stage non-small cell lung cancer (ES NSCLC).
K. A. Gold
No relevant relationships to disclose
J. J. Lee
No relevant relationships to disclose
Y. Ping
No relevant relationships to disclose
C. Behrens
No relevant relationships to disclose
D. Liu
No relevant relationships to disclose
H. Lee
No relevant relationships to disclose
J. S. Koo
No relevant relationships to disclose
R. Lotan
No relevant relationships to disclose
L. Solis
No relevant relationships to disclose
W. Rinsurongkawong
No relevant relationships to disclose
D. J. Stewart
No relevant relationships to disclose
W. L. Hofstetter
No relevant relationships to disclose
S. Swisher
No relevant relationships to disclose
S. M. Lippman
No relevant relationships to disclose
I. I. Wistuba
No relevant relationships to disclose
W. K. Hong
No relevant relationships to disclose
E. S. Kim
No relevant relationships to disclose